VCM
RYTM icon

Versant Capital Management’s Rhythm Pharmaceuticals RYTM Stock Holding History

Versant Capital Management’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4K Hold
36
– – ﹤0.01% 2468
2026
Q1 		$3.13K Hold
36
– – ﹤0.01% 2485
2025
Q4 		$3.85K Hold
36
– – ﹤0.01% 2336
2025
Q3 		$3.64K Hold
36
– – ﹤0.01% 2312
2025
Q2 		$2.27K Sell
36
-19
-35% -$1.16K ﹤0.01% 2354
2025
Q1 		$2.91K Buy
+55
New +$3.05K ﹤0.01% 2208

Other funds holding RYTM

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return
EOJOAM
E. Ohman J:or Asset Management Stockholm, Sweden $4.3B AUM 29.55% 1-Year Est. Return
AWM
Avior Wealth Management Omaha, Nebraska $3.8B AUM 23.28% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
EWP
Elevation Wealth Partners Santa Rosa, California $334M AUM 26.48% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Versant Capital Management's RYTM Position: Q2 2026 in Review

Versant Capital Management held its Rhythm Pharmaceuticals (RYTM) position steady in Q2 2026 at 36 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #2468.

Versant Capital Management first reported a position in RYTM in Q1 2025 and has held it in 6 quarters since. 20 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

  • Versant Capital Management held 36 shares of Rhythm Pharmaceuticals worth $4K as of Q2 2026.
  • Versant Capital Management left its Rhythm Pharmaceuticals share count unchanged in Q2 2026.
  • Rhythm Pharmaceuticals made up ﹤0.01% of Versant Capital Management's portfolio in Q2 2026, its #2468 holding.
  • Versant Capital Management first reported a position in Rhythm Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • 20 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.